• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭病理生理学的潜在机制:冰山一角。

Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg.

作者信息

Miranda-Silva Daniela, Lima Tânia, Rodrigues Patrícia, Leite-Moreira Adelino, Falcão-Pires Inês

机构信息

Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.

出版信息

Heart Fail Rev. 2021 May;26(3):453-478. doi: 10.1007/s10741-020-10042-0. Epub 2021 Jan 7.

DOI:10.1007/s10741-020-10042-0
PMID:33411091
Abstract

Heart failure with preserved ejection fraction (HFpEF) is a multifaceted syndrome with a complex aetiology often associated with several comorbidities, such as left ventricle pressure overload, diabetes mellitus, obesity, and kidney disease. Its pathophysiology remains obscure mainly due to the complex phenotype induced by all these associated comorbidities and to the scarcity of animal models that adequately mimic HFpEF. Increased oxidative stress, inflammation, and endothelial dysfunction are currently accepted as key players in HFpEF pathophysiology. However, we have just started to unveil HFpEF complexity and the role of calcium handling, energetic metabolism, and mitochondrial function remain to clarify. Indeed, the enlightenment of such cellular and molecular mechanisms represents an opportunity to develop novel therapeutic approaches and thus to improve HFpEF treatment options. In the last decades, the number of research groups dedicated to studying HFpEF has increased, denoting the importance and the magnitude achieved by this syndrome. In the current technological and web world, the amount of information is overwhelming, driving us not only to compile the most relevant information about the theme but also to explore beyond the tip of the iceberg. Thus, this review aims to encompass the most recent knowledge related to HFpEF or HFpEF-associated comorbidities, focusing mainly on myocardial metabolism, oxidative stress, and energetic pathways.

摘要

射血分数保留的心力衰竭(HFpEF)是一种多方面的综合征,病因复杂,常与多种合并症相关,如左心室压力过载、糖尿病、肥胖和肾脏疾病。其病理生理学仍不明确,主要是由于所有这些相关合并症所诱导的复杂表型,以及缺乏充分模拟HFpEF的动物模型。氧化应激增加、炎症和内皮功能障碍目前被认为是HFpEF病理生理学的关键因素。然而,我们才刚刚开始揭示HFpEF的复杂性,钙处理、能量代谢和线粒体功能的作用仍有待阐明。事实上,阐明这些细胞和分子机制代表了开发新治疗方法的机会,从而改善HFpEF的治疗选择。在过去几十年里,致力于研究HFpEF的研究小组数量有所增加,这表明该综合征的重要性和影响力。在当前的技术和网络世界中,信息量巨大,这不仅促使我们汇编有关该主题的最相关信息,还促使我们探索冰山一角之外的内容。因此,本综述旨在涵盖与HFpEF或HFpEF相关合并症的最新知识,主要关注心肌代谢、氧化应激和能量途径。

相似文献

1
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg.射血分数保留的心力衰竭病理生理学的潜在机制:冰山一角。
Heart Fail Rev. 2021 May;26(3):453-478. doi: 10.1007/s10741-020-10042-0. Epub 2021 Jan 7.
2
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.一种新型射血分数保留心力衰竭模式:合并症通过冠状动脉微血管内皮炎症导致心肌功能障碍和重构。
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15.
3
Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs.射血分数保留的心力衰竭及其合并症机制研究的最新进展——微小RNA的作用
Eur J Clin Invest. 2024 Mar;54(3):e14130. doi: 10.1111/eci.14130. Epub 2023 Dec 9.
4
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.射血分数保留的心力衰竭和射血分数降低的心力衰竭中生长激素轴、肾上腺素能信号传导及钙处理相关基因的心肌表达
ESC Heart Fail. 2021 Apr;8(2):1681-1686. doi: 10.1002/ehf2.13067. Epub 2021 Jan 29.
5
Heart failure with preserved ejection fraction in hypertension.高血压性射血分数保留的心力衰竭
Curr Opin Cardiol. 2016 Jul;31(4):410-6. doi: 10.1097/HCO.0000000000000292.
6
Heart Failure with Preserved Ejection Fraction-a Concise Review.射血分数保留的心力衰竭——简要综述。
Curr Cardiol Rep. 2020 Jul 9;22(9):82. doi: 10.1007/s11886-020-01349-3.
7
OPLAH ablation leads to accumulation of 5-oxoproline, oxidative stress, fibrosis, and elevated fillings pressures: a murine model for heart failure with a preserved ejection fraction.OPLAH 消融导致 5-氧脯氨酸积累、氧化应激、纤维化和充盈压升高:射血分数保留的心力衰竭的小鼠模型。
Cardiovasc Res. 2018 Dec 1;114(14):1871-1882. doi: 10.1093/cvr/cvy187.
8
Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design.射血分数保留的心力衰竭(HFpEF)病理生理学研究(IDENTIFY-HF):除衰老和合并症的血管效应外,动脉僵硬度增加是否与HFpEF相关?原理与设计。
BMJ Open. 2019 Nov 19;9(11):e027984. doi: 10.1136/bmjopen-2018-027984.
9
Inflammation in HFpEF: Key or circumstantial?射血分数保留的心力衰竭中的炎症:关键因素还是次要因素?
Int J Cardiol. 2015;189:259-63. doi: 10.1016/j.ijcard.2015.04.110. Epub 2015 Apr 15.
10
Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.心肌细胞功能病因在射血分数保留心力衰竭中有独特表现——一种新的临床前模型。
J Am Heart Assoc. 2018 Jun 1;7(11):e007451. doi: 10.1161/JAHA.117.007451.

引用本文的文献

1
Angiotensin-Converting Enzyme Inhibitory Peptide Derived from Ultrafine Pomace Powder: and Analysis.源自超细微果渣粉的血管紧张素转换酶抑制肽:及其分析
J Agric Food Chem. 2025 Aug 13;73(32):20149-20162. doi: 10.1021/acs.jafc.5c01994. Epub 2025 Jul 30.
2
Changes in tumor and cardiac metabolism upon immune checkpoint.免疫检查点作用下肿瘤和心脏代谢的变化
Basic Res Cardiol. 2025 Feb;120(1):133-152. doi: 10.1007/s00395-024-01092-8. Epub 2024 Dec 10.
3
Geniposide alleviates heart failure with preserved ejection fraction in mice by regulating cardiac oxidative stress via MMP2/SIRT1/GSK3β pathway.

本文引用的文献

1
Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns.心脏代谢性心力衰竭与射血分数保留的心力衰竭:仍在追寻独角兽
JACC Basic Transl Sci. 2019 Jun 24;4(3):422-424. doi: 10.1016/j.jacbts.2019.05.003. eCollection 2019 Jun.
2
Western Diet-Fed, Aortic-Banded Ossabaw Swine: A Preclinical Model of Cardio-Metabolic Heart Failure.西方饮食喂养、主动脉缩窄的奥萨巴猪:心脏代谢性心力衰竭的临床前模型。
JACC Basic Transl Sci. 2019 Jun 24;4(3):404-421. doi: 10.1016/j.jacbts.2019.02.004. eCollection 2019 Jun.
3
Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology.
栀子苷通过调节 MMP2/SIRT1/GSK3β 通路减轻射血分数保留型心力衰竭小鼠的心脏氧化应激。
Acta Pharmacol Sin. 2024 Dec;45(12):2567-2578. doi: 10.1038/s41401-024-01341-5. Epub 2024 Jul 26.
4
Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure.心力衰竭患者内皮功能障碍的分子机制及治疗意义。
Int J Mol Sci. 2023 Feb 21;24(5):4321. doi: 10.3390/ijms24054321.
5
Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction.比较肝纤维化评分对射血分数保留心力衰竭患者死亡率和发病率的预测价值。
ESC Heart Fail. 2023 Jun;10(3):1771-1780. doi: 10.1002/ehf2.14336. Epub 2023 Mar 2.
6
The Interaction of Gut Microbiota and Heart Failure with Preserved Ejection Fraction: From Mechanism to Potential Therapies.射血分数保留的心力衰竭与肠道微生物群的相互作用:从机制到潜在治疗方法
Biomedicines. 2023 Feb 2;11(2):442. doi: 10.3390/biomedicines11020442.
7
Systems Biology in Chronic Heart Failure-Identification of Potential miRNA Regulators.慢性心力衰竭中的系统生物学——潜在miRNA调节因子的鉴定
Int J Mol Sci. 2022 Dec 3;23(23):15226. doi: 10.3390/ijms232315226.
8
HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction.HFpEF 与心房颤动:代谢异常、生物标志物与血管内皮功能障碍的神秘相互作用。
Dis Markers. 2022 Oct 25;2022:9539676. doi: 10.1155/2022/9539676. eCollection 2022.
9
Non-invasive assessment of HFpEF in mouse models: current gaps and future directions.无创评估小鼠模型中的 HFpEF:当前的差距和未来的方向。
BMC Med. 2022 Oct 14;20(1):349. doi: 10.1186/s12916-022-02546-3.
10
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.心力衰竭射血分数保留与降低患者的生物标志物谱:DIAST-CHF 研究结果。
ESC Heart Fail. 2023 Feb;10(1):200-210. doi: 10.1002/ehf2.14167. Epub 2022 Oct 2.
射血分数保留的心力衰竭:心脏及非心脏病理生理学综述
Front Physiol. 2019 May 29;10:638. doi: 10.3389/fphys.2019.00638. eCollection 2019.
4
Mitochondrial electron transport chain, ROS generation and uncoupling (Review).线粒体电子传递链、ROS 生成和解偶联(综述)。
Int J Mol Med. 2019 Jul;44(1):3-15. doi: 10.3892/ijmm.2019.4188. Epub 2019 May 8.
5
Energetic Dysfunction Is Mediated by Mitochondrial Reactive Oxygen Species and Precedes Structural Remodeling in Metabolic Heart Disease.能量功能障碍是由线粒体活性氧物质介导的,并先于代谢性心脏病的结构重塑。
Antioxid Redox Signal. 2019 Sep 1;31(7):539-549. doi: 10.1089/ars.2018.7707. Epub 2019 Jun 25.
6
Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction.微血管稀疏与射血分数保留的心力衰竭
Front Cardiovasc Med. 2019 Feb 28;6:15. doi: 10.3389/fcvm.2019.00015. eCollection 2019.
7
Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.左室射血分数保留的心力衰竭中的线粒体功能障碍。
Circulation. 2019 Mar 12;139(11):1435-1450. doi: 10.1161/CIRCULATIONAHA.118.036259.
8
Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy.自噬对于高脂肪饮食诱导的糖尿病心肌病期间维持心脏功能至关重要。
Circ Res. 2019 Apr 26;124(9):1360-1371. doi: 10.1161/CIRCRESAHA.118.314607.
9
Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction.人类压力超负荷或缺血性心脏病伴射血分数保留或降低时线粒体的形态、动力学和功能。
Circ Heart Fail. 2019 Feb;12(2):e005131. doi: 10.1161/CIRCHEARTFAILURE.118.005131.
10
Role of mitochondrial Ca homeostasis in cardiac muscles.线粒体钙稳态在心肌中的作用。
Arch Biochem Biophys. 2019 Mar 15;663:276-287. doi: 10.1016/j.abb.2019.01.027. Epub 2019 Jan 23.